Health Care • Biotechnology: Laboratory Analytical Instruments
$480.07 ▲ +3.19
(+0.67%)
MKT CAP: $47.17B • VOL: 883.3K
52W L $283 52W H $482
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$403
MEDIAN
$538
MEAN
$547
HIGH
$653
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE WAT TAPE
WAT // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $580.88 | $552.08 | 2025-02-14 | $436.86 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $604.89 | $566.48 | 2025-02-06 | $451.27 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $547.28 | $528.08 | 2025-01-29 | $460.87 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $489.67 | — | 2025-01-17 | $470.47 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $422.46 | $456.07 | 2025-01-09 | $427.26 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $571.28 | $499.27 | 2024-12-18 | $417.66 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $465.67 | $484.87 | 2024-12-04 | $446.47 | -4.3% | 48% | C |